A selective peroxisome proliferator-activated receptor-β/δ agonist attenuates neointimal hyperplasia after wire-mediated arterial injury

Bibliography

• Leimgruber PP, Roubin GS, Hollman J, et al. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 1986;73:710-17
   PubMed Web of Science ®Google Scholar
• Holmes DR Jr. In-stent restenosis. Rev Cardiovasc Med 2001;2:115-19
   PubMedGoogle Scholar
• Hehrlein C, Gollan C, Donges K, et al. Low-dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits. Circulation 1995;92:1570-5
   PubMed Web of Science ®Google Scholar
• Indolfi C, Torella D, Coppola C, et al. Physical training increases eNOS vascular expression and activity and reduces restenosis after balloon angioplasty or arterial stenting in rats. Circ Res 2002;91:1190-7
   PubMed Web of Science ®Google Scholar
• Inoue T, Croce K, Morooka T, et al. Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis. JACC Cardiovasc Interv 2011;4:1057-66
   PubMed Web of Science ®Google Scholar
• Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999;20:649-88
   PubMed Web of Science ®Google Scholar
• Piqueras L, Reynolds AR, Hodivala-Dilke KM, et al. Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis. Arterioscler Thromb Vasc Biol 2007;27:63-9
   PubMed Web of Science ®Google Scholar
• Takata Y, Liu J, Yin F, et al. PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis. Proc Natl Acad Sci USA 2008;105:4277-82
   PubMed Web of Science ®Google Scholar
• Bishop-Bailey D. PPARs and angiogenesis. Biochem Soc Trans 2011;39:1601-5
   PubMed Web of Science ®Google Scholar
• Stephen RL, Gustafsson MC, Jarvis M, et al. Activation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell lines. Cancer Res 2004;64:3162-70
   PubMed Web of Science ®Google Scholar
• Sata M, Maejima Y, Adachi F, et al. A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol 2000;32:2097-104
   PubMed Web of Science ®Google Scholar
• Sznaidman ML, Haffner CD, Maloney PR, et al. Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)–synthesis and biological activity. Bioorg Med Chem Lett 2003;13:1517-21
   PubMed Web of Science ®Google Scholar
• Guo JP, Panday MM, Consigny PM, et al. Mechanisms of vascular preservation by a novel NO donor following rat carotid artery intimal injury. Am J Physiol 1995;269:H1122-31
   PubMed Web of Science ®Google Scholar
• Suzuki J, Ogawa M, Takayama K, et al. Ultrasound-microbubble-mediated intercellular adhesion molecule-1 small interfering ribonucleic acid transfection attenuates neointimal formation after arterial injury in mice. J Am Coll Cardiol 2010;55:904-13
   PubMed Web of Science ®Google Scholar
• Ogawa M, Suzuki J, Kosuge H, et al. The mechanism of anti-inflammatory effects of prostaglandin E2 receptor 4 activation in murine cardiac transplantation. Transplantation 2009;87:1645-53
   PubMed Web of Science ®Google Scholar
• Hamaya R, Ogawa M, Kobayashi N, et al. A novel IKK inhibitor prevents progression of restenosis after arterial injury in mice. Int Heart J 2012;53:133-8
   PubMed Web of Science ®Google Scholar
• Dehghani F, Haji Molla Hoseini M, Memarnejadian A, et al. Immunomodulatory activities of chitin microparticles on leishmania major-infected murine macrophages. Arch Med Res 2011;42(7):572-6
   PubMed Web of Science ®Google Scholar
• Yoshimura K, Tanimoto A, Abe T, et al. Shiga toxin 1 and 2 induce apoptosis in the amniotic cell line WISH. J Soc Gynecol Investig 2002;9:22-6
   PubMedGoogle Scholar
• Ogawa M, Suzuki J, Hishikari K, et al. Clarithromycin attenuates acute and chronic rejection via matrix metalloproteinase suppression in murine cardiac transplantation. J Am Coll Cardiol 2008;51:1977-85
   PubMed Web of Science ®Google Scholar
• Saiki H, Suzuki J, Kosuge H, et al. Blockade of the 4-1BB pathway attenuates graft arterial disease in cardiac allografts. Int Heart J 2008;49:105-18
   PubMed Web of Science ®Google Scholar
• Botella LM, Sanchez-Elsner T, Sanz-Rodriguez F, et al. Transcriptional activation of endoglin and transforming growth factor-beta signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury. Blood 2002;100:4001-10
   PubMed Web of Science ®Google Scholar
• Daniel JM, Bielenberg W, Stieger P, et al. Time-course analysis on the differentiation of bone marrow-derived progenitor cells into smooth muscle cells during neointima formation. Arterioscler Thromb Vasc Biol 2010;30:1890-6
   PubMed Web of Science ®Google Scholar
• Iwata H, Manabe I, Fujiu K, et al. Bone marrow-derived cells contribute to vascular inflammation but do not differentiate into smooth muscle cell lineages. Circulation 2010;122:2048-57
   PubMed Web of Science ®Google Scholar
• Hoofnagle MH, Thomas JA, Wamhoff BR, et al. Origin of neointimal smooth muscle: we've come full circle. Arterioscler Thromb Vasc Biol 2006;26:2579-81
   PubMed Web of Science ®Google Scholar
• Feil S, Hofmann F, Feil R. SM22alpha modulates vascular smooth muscle cell phenotype during atherogenesis. Circ Res 2004;94:863-5
   PubMed Web of Science ®Google Scholar
• Barak Y, Liao D, He W, et al. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci USA 2002;99:303-8
   PubMed Web of Science ®Google Scholar
• Szatmari I, Pap A, Ruhl R, et al. PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J Exp Med 2006;203:2351-62
   PubMed Web of Science ®Google Scholar
• Di Paola R, Briguglio F, Paterniti I, et al. Emerging role of PPAR-beta/delta in inflammatory process associated to experimental periodontitis. Mediators Inflamm 2011;2011:787159
   PubMed Web of Science ®Google Scholar
• Di Paola R, Esposito E, Mazzon E, et al. GW0742, a selective PPAR-beta/delta agonist, contributes to the resolution of inflammation after gut ischemia/reperfusion injury. J Leukoc Biol 2010;88:291-301
   PubMed Web of Science ®Google Scholar
• Kapoor A, Shintani Y, Collino M, et al. Protective role of peroxisome proliferator-activated receptor-beta/delta in septic shock. Am J Respir Crit Care Med 2010;182:1506-15
   PubMed Web of Science ®Google Scholar
• Schober A. Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol 2008;28:1950-9
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim MY, Hwang JS, et al. PPARdelta inhibits IL-1beta-stimulated proliferation and migration of vascular smooth muscle cells via up-regulation of IL-1Ra. Cell Mol Life Sci 2010;67:2119-30
   PubMed Web of Science ®Google Scholar
• Lim HJ, Lee S, Park JH, et al. PPAR delta agonist L-165041 inhibits rat vascular smooth muscle cell proliferation and migration via inhibition of cell cycle. Atherosclerosis 2009;202:446-54
   PubMed Web of Science ®Google Scholar
• Haude M, Konorza TF, Kalnins U, et al. Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patients. Circulation 2003;107:1265-70
   PubMed Web of Science ®Google Scholar
• Jaffe R, Strauss BH. Late and very late thrombosis of drug-eluting stents: evolving concepts and perspectives. J Am Coll Cardiol 2007;50:119-27
   PubMed Web of Science ®Google Scholar
• Luscher TF, Steffel J, Eberli FR, et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 2007;115:1051-8
   PubMed Web of Science ®Google Scholar
• Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202
   PubMed Web of Science ®Google Scholar
• Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007;115:2435-41
   PubMed Web of Science ®Google Scholar
• Capranzano P, Dangas G. Late stent thrombosis: the last remaining obstacle in coronary interventional therapy. Curr Cardiol Rep 2012;14:408-17
   PubMedGoogle Scholar
• Hollingshead HE, Killins RL, Borland MG, et al. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines. Carcinogenesis 2007;28:2641-9
   PubMed Web of Science ®Google Scholar
• Park JH, Lee KS, Lim HJ, et al. The PPARdelta ligand L-165041 inhibits VEGF-induced angiogenesis, but the antiangiogenic effect is not related to PPARdelta. J Cell Biochem 2012;113:1947-54
   PubMed Web of Science ®Google Scholar